Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05028101 · ClinicalTrials.gov registry record · NA
The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05028101 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 7 participants.
The verdict
NCT05028101, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.
Interventions
- PROCEDURE Delayed autologous breast reconstruction
- BEHAVIORAL Perioperative Functional Medicine (FM) Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05028101
The ClinicalTrials.gov registry entry for NCT05028101 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Delayed autologous breast reconstruction is the first listed.
NCT05028101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05028101 about?
NCT05028101 is a clinical study titled "The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction". This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.
What is the current status of trial NCT05028101?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-20. Estimated completion is 2024-06-06.
What interventions are being tested in trial NCT05028101?
The interventions under investigation include: Delayed autologous breast reconstruction (PROCEDURE), Perioperative Functional Medicine (FM) Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05028101?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.